(Q68429082)

English

Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a

scientific article published on 01 October 1990

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

P Golino

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

M Rosolowsky

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

S K Yao

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

J McNatt

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

F De Clerck

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

L M Buja

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

J T Willerson

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 1990

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

Journal of Clinical Investigation

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

86

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1095-1102

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iliac artery mural thrombus formation. Effect of antiplatelet therapy on 111In-platelet deposition in baboons

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--II. Pharmacological effects in vivo and ex vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet Aggregation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioimmunoassay of Prostaglandins Fα, E1and E2in Human Plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continued incorporation of circulating radiolabeled fibrinogen into preformed coronary artery thrombi

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary excretion of prostaglandin E2, prostaglandin F2 alpha, and thromboxane B2 in normotensive and hypertensive subjects on varying sodium intakes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thromboxane a2: biosynthesis and effects on platelets

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelets interact with fibrin only after activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The biochemical pharmacology of thromboxane synthase inhibition in man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1172/JCI114813

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145320%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68429082&oldid=1753605357"